![]() |
QIAGEN launches careHPV Test in India for prevention of cervical cancer among women
QIAGEN N.V. today announced the commercial launch in India of its careHPV⢠Test, the only molecular diagnostic for high-risk human papillomavirus (HPV) designed to screen women in settings with limited healthcare infrastructure, such as areas lacking electricity, water or laboratories.
More... |
| All times are GMT -7. The time now is 08:55 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021